Abraham T - Search Results

1

In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients.

Chai SJ, Fong SCY, Gan CP, Pua KC, Lim PVH, Lau SH, Zain RB, Abraham T, Ismail SM, Abdul Rahman ZA, Ponniah S, Patel V, Cheong SC, Lim KP. Chai SJ, et al. Among authors: abraham t. Hum Vaccin Immunother. 2019;15(1):167-178. doi: 10.1080/21645515.2018.1520584. Epub 2018 Oct 12. Hum Vaccin Immunother. 2019. PMID: 30193086 Free PMC article.

2

Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma.

Khor GH, Froemming GR, Zain RB, Abraham TM, Lin TK. Khor GH, et al. Asian Pac J Cancer Prev. 2016;17(1):219-23. doi: 10.7314/apjcp.2016.17.1.219. Asian Pac J Cancer Prev. 2016. PMID: 26838213 Free article.

3

p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.

Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari KR, Abraham T, Abraham EK, Nair MK. Jayasurya R, et al. Among authors: abraham ek, abraham t. Int J Cancer. 2004 May 1;109(5):710-6. doi: 10.1002/ijc.20042. Int J Cancer. 2004. PMID: 14999779

4

Circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.

Abraham T, Balaram P. Abraham T, et al. Indian J Cancer. 1987 Sep;24(3):133-40. Indian J Cancer. 1987. PMID: 3450577 No abstract available.

5

CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.

Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Sathyan KM, et al. Among authors: abraham t. Oral Oncol. 2008 Jul;44(7):689-97. doi: 10.1016/j.oraloncology.2007.09.003. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061526

6

Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

John J, Cherian K, Abraham T, Appukuttan PS. John J, et al. Among authors: abraham t. Exp Biol Med (Maywood). 2020 Feb;245(3):254-265. doi: 10.1177/1535370220901493. Epub 2020 Jan 19. Exp Biol Med (Maywood). 2020. PMID: 31955603 Free PMC article.

7

Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma.

Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK, Kannan S. Jayasurya R, et al. Among authors: abraham ek, abraham t. Mod Pathol. 2005 Aug;18(8):1056-66. doi: 10.1038/modpathol.3800387. Mod Pathol. 2005. PMID: 15731778 Free article.

8

Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma.

Sathyan KM, Sailasree R, Jayasurya R, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Kannan S. Sathyan KM, et al. Among authors: abraham ek, abraham t. J Cancer Res Clin Oncol. 2006 Sep;132(9):601-9. doi: 10.1007/s00432-006-0111-y. Epub 2006 Jun 10. J Cancer Res Clin Oncol. 2006. PMID: 16767431

9

Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility.

Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Sathyan KM, et al. Among authors: abraham t. Oral Oncol. 2006 Jul;42(6):607-13. doi: 10.1016/j.oraloncology.2005.10.019. Epub 2006 Feb 20. Oral Oncol. 2006. PMID: 16488657

10

Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: a preliminary evaluation.

Balaram P, Pillai MR, Abraham T, Nalinakumari KR, Meenattoor G, Kannan S, Hareendran NK, Nair MK. Balaram P, et al. Among authors: abraham t. J Cancer Res Clin Oncol. 1992;118(6):408-10. doi: 10.1007/BF01629422. J Cancer Res Clin Oncol. 1992. PMID: 1618887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters